Alzheimer's disease begins with a long period during which abnormal amyloid and tau proteins build up in the brain without ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
Consistent with the approach taken by other alternative payment models, GUIDE frames the emergency department as a negative ...